Home / Centerstage / 2017 / december / Week 3 /
Laboratories in the United States are now permitted to manufacture strains of influenza, SARS, and MERS, following a ban imposed after safety breaches. Each research proposal must be approved by a scientific review panel, ensuring the risks are justified by the potential benefits. Critics express concerns about the potential for accidental pandemics, while supporters argue that the research is necessary for global security.
Tuesday, 19 December, 2017